chr19-17817059-C-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 1P and 1B. PP3BS2_Supporting
The NM_005543.4(INSL3):c.191G>T(p.Arg64Leu) variant causes a missense, splice region change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000391 in 1,612,712 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 2/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_005543.4 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
INSL3 | NM_005543.4 | c.191G>T | p.Arg64Leu | missense_variant, splice_region_variant | 2/2 | ENST00000317306.8 | NP_005534.2 | |
INSL3 | NM_001265587.2 | c.286G>T | p.Val96Leu | missense_variant, splice_region_variant | 3/3 | NP_001252516.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
INSL3 | ENST00000598577.1 | c.213G>T | p.Arg71Ser | missense_variant | 2/2 | 1 | ENSP00000469309 | |||
INSL3 | ENST00000317306.8 | c.191G>T | p.Arg64Leu | missense_variant, splice_region_variant | 2/2 | 1 | NM_005543.4 | ENSP00000321724 | P1 | |
INSL3 | ENST00000379695.5 | c.286G>T | p.Val96Leu | missense_variant, splice_region_variant | 3/3 | 1 | ENSP00000369017 |
Frequencies
GnomAD3 genomes AF: 0.000269 AC: 41AN: 152182Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000649 AC: 16AN: 246658Hom.: 0 AF XY: 0.0000374 AC XY: 5AN XY: 133728
GnomAD4 exome AF: 0.0000151 AC: 22AN: 1460412Hom.: 0 Cov.: 31 AF XY: 0.0000124 AC XY: 9AN XY: 726508
GnomAD4 genome AF: 0.000269 AC: 41AN: 152300Hom.: 0 Cov.: 31 AF XY: 0.000282 AC XY: 21AN XY: 74472
ClinVar
Submissions by phenotype
Cryptorchidism Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Victorian Clinical Genetics Services, Murdoch Childrens Research Institute | May 06, 2021 | Based on the classification scheme VCGS_Germline_v1.3.4, this variant is classified as 3B-VUS. Following criteria are met: 0105 - The mechanism of disease for this gene is not clearly established. (I) 0107 - This gene is associated with autosomal dominant disease. (I) 0200 - Variant is predicted to result in a missense amino acid change from arginine to leucine. (I) 0219 - This variant encodes a different missense (NM_001265587.1(INSL3):c.286G>T; p.(Val96Leu)) in an alternative transcript, due to alternative exon splicing leading to a shifted reading frame. (I) 0251 - This variant is heterozygous. (I) 0302 - Variant is present in gnomAD (v3) <0.001 for a dominant condition (39 heterozygotes, 0 homozygotes). (SP) 0309 - An alternative amino acid change at the same position has been observed in gnomAD (v2) (1 heterozygote, 0 homozygotes). (I) 0600 - Variant is located in the annotated IlGF relaxin like domain (NCBI). (I) 0502 - Missense variant with conflicting in silico predictions and uninformative conservation. (I) 0705 - No comparable missense variants have previous evidence for pathogenicity. (I) 0807 - This variant has no previous evidence of pathogenicity. (I) 0905 - No published segregation evidence has been identified for this variant. (I) 1007 - No published functional evidence has been identified for this variant. (I) 1208 - Inheritance information for this variant is not currently available in this individual. (I) Legend: (SP) - Supporting pathogenic, (I) - Information, (SB) - Supporting benign - |
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 13, 2021 | The c.191G>T (p.R64L) alteration is located in exon 2 (coding exon 2) of the INSL3 gene. This alteration results from a G to T substitution at nucleotide position 191, causing the arginine (R) at amino acid position 64 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at